The impact of the COVID-19 pandemic on the diagnosis, treatment, and prognosis of ovarian cancer in the United States: a retrospective cohort study based on the SEER database
The survival outcomes of the pre-COVID-19 group and the post-COVID-19 group were relatively consistent, likely due to the short follow-up. Future research is necessary to continue monitoring the outcomes of patients in the post-COVID-19 group to determine its long-term impact.
Authors
- Qin Xu (ORCID: https://orcid.org/0000-0002-3689-0266)
- Haixin He
- Lele Zang (ORCID: https://orcid.org/0000-0002-4151-3182)
- Jing Liu‐Zeng (ORCID: https://orcid.org/0000-0001-7108-6452)
- Lele Chang (ORCID: https://orcid.org/0000-0002-1305-9058)
- Xuemei Zhang (ORCID: https://orcid.org/0000-0003-0705-4231)
- Li Li (ORCID: https://orcid.org/0000-0002-6789-2328)
- Yuqin Wang (ORCID: https://orcid.org/0000-0002-2144-0473)
- Tongyu Liu (ORCID: https://orcid.org/0000-0002-8579-2144)
Institutions
- Fujian Medical University (CN)
- Fujian Provincial Cancer Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1007/s12672-025-02205-y
- Citations
- 2
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.40
Funders
- Natural Science Foundation of Fujian Province
- Fujian Provincial Health Commission